| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | 121.732 | 565.889 | 620.764 |
| Total Income - EUR | - | - | - | - | - | - | - | 121.787 | 628.296 | 620.783 |
| Total Expenses - EUR | - | - | - | - | - | - | - | 69.646 | 374.425 | 394.024 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | 52.141 | 253.870 | 226.758 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | 50.756 | 247.588 | 187.008 |
| Employees | - | - | - | - | - | - | - | 1 | 1 | 1 |
Check the financial reports for the company - Next Gen Medical Solutions S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | 160.302 | 157.048 | 581.491 |
| Current Assets | - | - | - | - | - | - | - | 489.652 | 806.247 | 255.473 |
| Inventories | - | - | - | - | - | - | - | 8.583 | 158.326 | 101.904 |
| Receivables | - | - | - | - | - | - | - | 433.973 | 568.820 | 79.720 |
| Cash | - | - | - | - | - | - | - | 47.096 | 79.100 | 73.848 |
| Shareholders Funds | - | - | - | - | - | - | - | 205.501 | 452.466 | 516.326 |
| Social Capital | - | - | - | - | - | - | - | 154.745 | 154.276 | 153.414 |
| Debts | - | - | - | - | - | - | - | 444.452 | 510.828 | 320.638 |
| Income in Advance | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Next Gen Medical Solutions S.r.l.